Kensington, MD, USA and Munich/Martinsried, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- Galimedix Therapeutics earns milestone payment in ophthalmology partnership ...

The Contract Development and Manufacturing Organization (CDMO) industry in India is a fast-growing segment of the pharmaceutical sector that provides outsourced drug development and manufacturing ...

Q4 2025 earnings call: nimacimab + semaglutide data, higher-dose expansion, Halozyme SC plans, 2026 catalysts—read now.

Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering ...

The Chinese biotech put the idea to the test in a phase 2 trial of a subcutaneous depot formulation of its GLP-1 receptor agonist ASC30. U.S. investigators randomized 65 people with obesity or who ...

SHINKEI THERAPEUTICS RECEIVES FDA CLEARANCE TO PROCEED WITH PHASE 1 CLINICAL TRIAL FOR MR-101 AND COMPLETES PHASE 2 ...

Source: CUT to develop snakebite treatment medicine – herald Walter Nyamukondiwa-Mashonaland West Bureau Chief ZIMBABWE could soon benefit from a locally developed treatment for snakebites following ...

Forma Life Sciences has launched as an independent, operator-owned contract development and manufacturing organization (CDMO) in the U.S. The new CDMO is focused on oral solid dosage formulation ...

This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...

Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...

BioTechnique broadens capabilities with end‑to‑end fill‑finish, advanced lyophilization development, and integrated multi‑temperature 3PL support. YORK, PA, UNITED STATES, March 5, 2026 /EINPresswire.